Q4 2024 Earnings Call Transcript February 28, 2025 Rapid Micro Biosystems, Inc. reports earnings inline with expectations.

Revenue was in line with analyst estimates. Earnings per share (EPS) was also in line with analyst expectations. Looking ...

Rapid Micro Biosystems Inc (RPID) reports a 30% revenue increase and unveils a promising partnership with Millipore Sigma, despite ongoing financial challenges.

Robert Spignesi; President, Chief Executive Officer, Director; Rapid Micro Biosystems Inc Sean Wirtjes; Chief Financial Officer; Rapid Micro Biosystems Inc Thank you for standing by. My name is. Elisa ...

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) has a target price significantly below its current stock price, indicating a ...

The life sciences technology company posted a loss of $0.22 per share for Q4, $0.01 worse than the analyst estimate of -$0.21. Revenue came in at $8.2 million, beating the consensus estimate of $7.8 ...

Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.26 per share a year ago. These ...

Reports record fourth quarter 2024 total revenue of $8.2 million, representing 30% growth compared to fourth quarter 2023; recurring revenue increased by 27% compared to the fourth quarter of 2023.Ann ...

Reports record fourth quarter 2024 total revenue of $8.2 million, representing 30% growth compared to fourth quarter 2023; recurring revenue ...

Shares in Rapid Micro Biosystems jumped Friday in premarket trading after it said it signed an agreement with Merck's life science business to distribute its microbiology testing platform. Shares ...

Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the "Company" or "Rapid Micro"), an innovative life sciences technology company providing mission critical ...

Significantly extends commercial reach of Growth Direct through expanded global sales channels; enables opportunities for ...